Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1988 Jun;26(3):257–262. doi: 10.1007/BF00199938

Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors

Wei-Zen Wei 1,✉, Gloria H Heppner 1
PMCID: PMC11038726  PMID: 3260133

Abstract

Tumor infiltrating lymphocytes (TIL) were isolated by centrifugal elutriation from C4 mouse mammary tumors and characterized with regard to phenotype and natural killer (NK) activity. Tumors that had arisen spontaneously in prenoplastic hyperplastic alevolar nodules and tumors that had been passaged one to two times in either naive or presensitized mice were studied. Mice were sensitized by limited s.c. tumor growth and subsequent surgical removal of the tumor. The total numbers of T or B cells in the infiltrates were similar in spontaneous tumors and in passaged tumors from either naive or sensitized mice. The ratio of L3T4-positive to lyt-2-positive cells was reduced, however, from 1.10±0.2 in spontaneous tumors to 0.53±0.28 or 0.48±0.04 in passaged tumors from untreated or sensitized mice. The site of tumor implantation, whether intramammary fat pad or s.c., did not affect the profiles of the infiltrates. The TIL from both spontaneous and passaged tumors demonstrated enhanced NK activity relative to peripheral lymphoid cells. The TIL of passaged tumors sensitized mice, however, had lower NK activity than those from naive mice.

Keywords: Tumor Growth, Cancer Research, Natural Killer, Mammary Tumor, Lymphoid Cell

References

  • 1.Blazar BA, Heppner GH. In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors. J Immunol. 1978;120:1876. [PubMed] [Google Scholar]
  • 2.Buessow SC, Paul RD, Miller AM, Lopez DM. Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional activity. Int J Cancer. 1984;33:79. doi: 10.1002/ijc.2910330114. [DOI] [PubMed] [Google Scholar]
  • 3.Dammacco F, Miglietta A, Lospolluti M, Meneghini C, Bonomo L. Macrophages in skin cancer: Quantitative and functional studies. Tumori. 1979;65:309. doi: 10.1177/030089167906500305. [DOI] [PubMed] [Google Scholar]
  • 4.Eccles SA, Alexander P. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974;250:667. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
  • 5.Eremin D, Coombs RRA, Ashby J. Lymphocytes infiltrating human breeast cancers lack K-cell and show low level of NK-cell activity. Br J Cancer. 1981;44:166. doi: 10.1038/bjc.1981.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Evans R. Macrophages in syngeneic animal tumors. Transplantation. 1972;14:468. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  • 7.Hamlin ME. Possible host resistance in carcinoma of the breast: A histological study. Br J Cancer. 1968;22:283. doi: 10.1038/bjc.1968.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Haskill S, Koren H, Becker S, Fowler W, Walton L. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours. Br J Cancer. 1982;45:747. doi: 10.1038/bjc.1982.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Iochim HL. Correlation between tumor antigenicity, malignant potential and local host immune response. Contemp Top Immunobiol. 1980;10:213. doi: 10.1007/978-1-4684-3677-8_10. [DOI] [PubMed] [Google Scholar]
  • 10.Lala PK, McKenzie IFC. An analysis of T lymphocyte subsets in tumor-transplanted mice on the basis of lyt antigenic markers and functions. Immunology. 1982;47:663. [PMC free article] [PubMed] [Google Scholar]
  • 11.Loeffler DA, Keng PC, Wilson KM, Lord EM (1988) Comparison of fluorescence intensity of hoechst 33342 stained EMT6 tumor cells and tumor infiltrating host cells. Br J Cancer (in press) [DOI] [PMC free article] [PubMed]
  • 12.Mahoney KH, Miller BE, Heppner GH. FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associatd macrophages from metastatic and nonmetastatic mouse mammary tumors. J Leuk Biol. 1985;38:573. doi: 10.1002/jlb.38.5.573. [DOI] [PubMed] [Google Scholar]
  • 13.May PM, Holmes EC, Golub SH. Depression of natural killer cytotoxiy activity in lymphocyte infiltrated human pulmonary tumors. Cancer Res. 1985;45:57. [PubMed] [Google Scholar]
  • 14.Medina D. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias occurring in BALB/c mice. J Nalt Cancer Inst. 1976;57:1185. doi: 10.1093/jnci/57.5.1185. [DOI] [PubMed] [Google Scholar]
  • 15.Miller FR. Concomitant tumor immunity in the mammary gland. Cancer Immunol Immunother. 1985;20:219. doi: 10.1007/BF00205580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mule JJ, Hellstrom I, Hellstrom KE. Cell surface phenotypes of radiolabelled immune long-lived lymphocytes that selectively localize in syngeneic tumors. Am J Pathol. 1982;107:142. [PMC free article] [PubMed] [Google Scholar]
  • 17.Pross HF, Kerbel KS. An assessment of intra-tumour phagocytes and surface marker bearing cells in a series of autochthonous and early passaged chemically-induced murine sarcomas. J Natl Cancer Inst. 1976;57:1157. doi: 10.1093/jnci/57.5.1157. [DOI] [PubMed] [Google Scholar]
  • 18.Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981;1:51. doi: 10.1007/BF00915477. [DOI] [PubMed] [Google Scholar]
  • 19.Rabinowich H, Steiner Z, Klajman A. Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: Different target cell specificities of Nk-like and cytotoxic T-cell clones. Cell Immunol. 1987;104:210. doi: 10.1016/0008-8749(87)90023-2. [DOI] [PubMed] [Google Scholar]
  • 20.Rios AM, Miller FR, Heppner GH. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties. Cancer Immunol Immunother. 1983;15:87. doi: 10.1007/BF00199696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ruppert B, Wei WZ, Medina D, Heppner GH. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines. J Natl Cancer Inst. 1978;61:1165. [PubMed] [Google Scholar]
  • 22.Sanderson RJ, Bird KE, Palmer NF, Breman J. Design principles for a counterflow centrifugation cell separation chamber. Anal Biochem. 1976;71:615. doi: 10.1016/s0003-2697(76)80036-x. [DOI] [PubMed] [Google Scholar]
  • 23.Swain SL, Dialynas DP, Fitch FW, English M. Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J Immunol. 1984;132:1118. [PubMed] [Google Scholar]
  • 24.Underwood JCE. Lymphorecticular infiltration in human tumours: Prognostic and biological implications: A Review. Br J Cancer. 1974;30:538. doi: 10.1038/bjc.1974.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Vose BM. Cytotoxicity of adherent cells associated with some human tumors and lung tissues. Cancer Immunol Immunother. 1978;5:173. [Google Scholar]
  • 26.Vose BM. Quantitation of proliferative and cytotoxic precursor cells directed against human tumors: Limiting dilution analysis in peripheral blood and at the tumor site. Int J Cancer. 1982;30:135. doi: 10.1002/ijc.2910300202. [DOI] [PubMed] [Google Scholar]
  • 27.Wei WZ, Malone K, Mahoney K, Heppner GH. Characterization of lymphocytic infiltrates in normal, preneoplastic and neoplastic mouse mammary tissues. Cancer Res. 1986;46:2680. [PubMed] [Google Scholar]
  • 28.Wei WZ, Heppner G. Natural killer activity of lymphocytic infiltrates in mouse mammary lesions. Br J Cancer. 1987;55:589. doi: 10.1038/bjc.1987.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wei WZ, Ratner S, Malone K, Mueller C, Winkelhake J, Heppner GH. Characterization of mouse mammary lesion-infiltrating lymphocytes cultured with interleukin-2. Proc Am Assoc Cancer Res. 1987;28:373. [Google Scholar]
  • 30.Whitwell HL, Hughes HPA, Moore M, Ahmed A. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant breast disease. Br J Cancer. 1984;49:161. doi: 10.1038/bjc.1984.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zettergren JG, Luberoff DE, Pretlow TG. Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of Ficoll in tissue culture medium. J Immunol. 1973;111:836. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES